Researchers found that a new method called optical genome mapping (OGM) is proving effective in diagnosing rare diseases that traditional genetic tests often miss. In recent studies, OGM has been shown to resolve cases that were previously unexplained, increasing diagnostic yield by 5-17% in certain populations. This is particularly significant for the estimated 1 in 15 people affected by rare diseases, many of which have a genetic basis. By identifying structural variants in genes that other methods overlook, OGM could help you and your loved ones find answers when facing mysterious health challenges.

This advancement matters because it could lead to better health outcomes for individuals with rare genetic conditions. For example, in studies involving conditions like Duchenne Muscular Dystrophy and various neurodevelopmental disorders, OGM has clarified genetic disruptions that are crucial for effective treatment planning. The ability to pinpoint these genetic changes means that healthcare providers can offer more accurate diagnoses and potentially more effective therapies tailored to specific genetic profiles.

The evidence supporting OGM’s effectiveness comes from a growing body of research, with 28 publications released in just the first quarter of 2026. These studies include both small and larger cohorts, demonstrating OGM’s ability to enhance the detection of complex genomic variations that conventional methods, such as whole genome sequencing, often miss. While the results are promising, OGM is still in the early stages of widespread clinical application, and further research is needed to fully establish its capabilities.

If you or someone you know is navigating the complexities of a rare disease, staying informed about advancements like OGM could be beneficial. Discussing these options with a healthcare provider might open new doors for diagnosis and treatment, especially if previous tests have not provided clear answers.

Source: globenewswire.com